Latest KFF Health News Content

Latest KFF Health News Stories

IRS Aggressively Enforcing Employer Mandate Despite Trump’s Promise That Health Law Is All But Dead

Morning Briefing

Business groups want relief from the mandate, but lawmakers have little appetite to take up any more changes in this politically charged election year. Meanwhile, Idaho officials are still trying to figure out ways to sell plans that don’t comply with health law regulations.

‘Pharma Folks Are Nervous’ As Trump Gears Up For Major Speech On Curbing Drug Prices

Morning Briefing

This week’s planned speech is expected to offer a “comprehensive strategy” that administration officials say will result in a “profound modernization” of how the government pays for some drugs. But the pharma industry is watching anxiously in case President Donald Trump goes off script.

In Search Of Migraine Treatments, Genetic Researchers Trace Variations Through Families

Morning Briefing

Scientists studying families with migraines find evidence that hundreds of genetic variants can determine the symptoms and severity of the debilitating disease. In other public health news today: brain implants, the CDC’s disease detective program, brain trauma, breast cancer and menopause.

Administration Urged To Use Workaround To Slash Cost Of Pricey Anti-Overdose Drug

Morning Briefing

Baltimore’s health department and a national advocacy group wrote to the Trump administration asking officials to take action. Meanwhile, Mayor Bill de Blasio wants to make New York City a pioneer in creating supervised safe injection sites.

Congressional Oversight Lags Far Behind Fast-Growing Commercial DNA Testing

Morning Briefing

Despite consumer unease about their DNA privacy, especially on the heels of the Golden State Killer case, Congress has made no moves to update the 2008 Genetic Information Nondiscrimination Act, the lone law in this field.

Health Insurers On ‘Hot Streak’ Despite Worries Over Nasty Flu Season

Morning Briefing

One big reason for the Q1 windfall is the tax cuts passed by Congress last year, which in some cases more than halved what the insurers owe the government. Meanwhile, conservative groups are drawing up a new “repeal” plan, but Republicans aren’t sold.

‘Pharma Bro’ Shkreli Is In Prison, But Daraprim’s Price Is Still High

KFF Health News Original

The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.